|
 |
|
|
|
|
89. J. Boik, Cancer and Natural Medicine (Princeton, Minn.: Oregon Medical Press, 1995), 150. |
|
|
|
 |
|
|
|
|
90. G. Pratesi et al., "Differential Efficacy of Flavone Acetic Acid Against Liver Versus Lung Metastases in a Human Tumor Xenograft," British Journal of Cancer 63 (1): 71-74 (1991). |
|
|
|
 |
|
|
|
|
91. M.C. Bibby et al., "Anti-rumor Activity of Flavone Acetic Acid (NSC 347512) in MiceInfluence of Immune Status," British Journal of Cancer 63 (1): 5742 (1991). |
|
|
|
 |
|
|
|
|
92. D.J. Kerr et al., "Phase I and Pharmacokinetic Study of Flavone Acetic Acid," Cancer Research 47 (24 Pt 1): 6776-81 (1987). |
|
|
|
 |
|
|
|
|
93. R.L. Hornung et al., "Augmentation of Natural Killer Activity, Induction of IFN and Development of Tumor Immunity During the Successful Treatment of Established Murine Renal Cancer Using Flavone Acetic Acid and IL-2," Journal of Immunology 141 (10): 3671-79 (1988). |
|
|
|
 |
|
|
|
|
94. R.H. Wiltrout et al., "Flavone-8-acetic Acid Augments Systemic Natural Killer Cell Activity and Synergizes with IL-2 for Treatment of Murine Renal Cancer," Journal of Immunology 140 (9): 3261-45 (1988). |
|
|
|
 |
|
|
|
|
95. G. Pratesi et al., "Role of T Cells and Tumor Necrosis Factor in Antitumor Activity and Toxicity of Flavone Acetic Acid," European Journal of Cancer 26 (10): 1079-83 (1990). |
|
|
|
 |
|
|
|
|
96. J. Boik, Cancer and Natural Medicine (Princeton, Minn.: Oregon Medical Press, 1995), 152-54. |
|
|
|
 |
|
|
|
|
97. J. Masquelier, OPCs in Practice (Rome, Italy: Alpha Omega Editrice, 1995), 118-20. |
|
|
|
 |
|
|
|
|
98. J.P. Boissin et al., "Chorioretinal Circulation and Dazzling Use of Procyanidol Oligomers," Bulletin Société d'Opthalmologie Fr 88 (173-74): 177-79 (1988). |
|
|
|
 |
|
|
|
|
99. L.M. Larocca et al., "Growth-inhibitory Effect of Quercetin and Presence of Type II Estrogen Binding Sites in Primary Human Transitional Cell Carcinomas," Journal of Urology 152 (3): 1029-33 (1994). |
|
|
|
 |
|
|
|
|
100. F.O. Ranelletti et al., "Growth-Inhibitory Effect of Quercetin and Presence of Type II Estrogen Binding Sites in Human Colon Cancer Cell Lines and Primary Colorectal Tumors," International Journal of Cancer 50 (3): 486-92 (1992). |
|
|
|
 |
|
|
|
|
101. M. Yoshida et al., "The Effect of Quercetin on Cell Cycle Progression and Growth of Human Gastric Cancer Cells," FEBS Letters 260 (1): 10-13 (1990). |
|
|
|
|
|